Therefore, to determine the function of MUC4 in the development of resistance to gemcitabine in pancreatic cancer cells, we assessed the effect of MUC4 down-regulation on gemcitabine-induced apoptosis in CD18/HPAF pancreatic cancer cells. This evidence concerns the gene ITGB2 and familial pancreatic carcinoma.